1. Home
  2. GRX vs NERV Comparison

GRX vs NERV Comparison

Compare GRX & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Gabelli Healthcare & Wellness Trust of Beneficial Interest

GRX

The Gabelli Healthcare & Wellness Trust of Beneficial Interest

HOLD

Current Price

$9.83

Market Cap

140.5M

Sector

Finance

ML Signal

HOLD

Logo Minerva Neurosciences Inc

NERV

Minerva Neurosciences Inc

HOLD

Current Price

$3.41

Market Cap

166.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRX
NERV
Founded
N/A
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
140.5M
166.4M
IPO Year
2007
2014

Fundamental Metrics

Financial Performance
Metric
GRX
NERV
Price
$9.83
$3.41
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $10.50
AVG Volume (30 Days)
21.7K
★ 120.5K
Earning Date
01-01-0001
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $41,175,600.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.80
$2.06
52 Week High
$10.20
$12.46

Technical Indicators

Market Signals
Indicator
GRX
NERV
Relative Strength Index (RSI) 42.97 33.97
Support Level $9.49 N/A
Resistance Level $9.73 $4.73
Average True Range (ATR) 0.12 0.28
MACD -0.01 -0.06
Stochastic Oscillator 26.74 7.98

Price Performance

Historical Comparison
GRX
NERV

About GRX The Gabelli Healthcare & Wellness Trust of Beneficial Interest

Gabelli Healthcare & WellnessRx Trust operates as a diversified closed-end management investment company. The investment objective of the fund is the long-term growth of capital. The fund invests at least its assets in equity securities and income-producing securities of domestic and foreign companies in the healthcare and wellness industries. It invests in various sectors, of which Health Care Providers & Services, Food, Health Care Equipment and Supplies, and Pharmaceuticals account for the majority of the weightage.

About NERV Minerva Neurosciences Inc

Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product candidate, Roluperidone, is in development for the treatment of negative symptoms in patients diagnosed with schizophrenia. Its Clinical-Stage Programs include Roluperidone and Seltorexant. The company's operations are organized into one operating and reportable segment focused on the development and commercialization of proprietary product candidates to treat patients suffering from CNS diseases.

Share on Social Networks: